RUA Life Sciences (RUA) Share Price, News & Analysis

Company Overview

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Key Stats

• Today's Range: 11.50 to 11.68
• 50-Day Range: 11.15 to 13.50
• 52-Week Range: 10.01 to 15.70
• Volume: 4,351 shs
• Average Volume: 141,961 shs
• Market Capitalization: £7.25 million
• P/E Ratio: N/A
• Dividend Yield: 1.44%
• Price Target: N/A
• Consensus Rating: N/A

RUA Stock Analysis - Frequently Asked Questions

How have RUA shares performed this year?

RUA Life Sciences' stock was trading at GBX 10.52 on January 1st, 2025. Since then, RUA shares have increased by 11.0% and is now trading at GBX 11.68.

How were RUA Life Sciences' earnings last quarter?

RUA Life Sciences plc (LON:RUA) issued its quarterly earnings results on Wednesday, December, 11th. The company reported $1.03 EPS for the quarter. RUA Life Sciences had a negative trailing twelve-month return on equity of 26.38% and a negative net margin of 65.72%.

How do I buy shares of RUA Life Sciences?

Shares of RUA stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

• Last Earnings: 12/11/2024
• Today: 7/16/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: LON:RUA
• CIK: N/A
• Web: www.rualifesciences.com
• Phone: 44 1294 317073
• Fax: N/A
• Employees: 48
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (4.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£2.66 million
• Net Margins: -65.72%
• Pretax Margin: N/A
• Return on Equity: -26.38%
• Return on Assets: -17.50%

Debt

• Debt-to-Equity Ratio: 5.42
• Current Ratio: 9.01
• Quick Ratio: 7.32

Sales & Book Value

• Annual Sales: £4.05 million
• Price / Sales: 1.79
• Cash Flow: GBX 4.87 per share
• Price / Cash Flow: 2.40
• Book Value: GBX 21.40 per share
• Price / Book: 0.55

Miscellaneous

• Outstanding Shares: 62,060,303
• Free Float: N/A
• Market Cap: £7.25 million
• Optionable: Not Optionable
• Beta: 1.21